Danielle Elizabeth Stephens, ARNP

Danielle Stephens practices at HCA Florida St. Lucie Hospital in Port Saint Lucie, Florida, part of HCA Healthcare.

Danielle Stephens' NPI, 1528200367, was assigned on March 25, 2009. Danielle Stephens holds Florida license 3288382.

Danielle Stephens' primary practice is HCA Florida St. Lucie Hospital, at 1800 SE Tiffany Ave, Port Saint Lucie, FL 34952 in St. Lucie County. The practice phone is (772) 335-4000.

Danielle Stephens' primary practice is HCA Florida St. Lucie Hospital in Port Saint Lucie, Florida, part of HCA Healthcare. Danielle Stephens is also affiliated with HCA Florida Lawnwood Hospital. The medical group on file is Hospital Medicine Services of Florida.

Dmand AI tracks the electronic health record (EHR) system at each site where Danielle Stephens practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Danielle Stephens' primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Danielle Stephens is licensed in Florida.

Dmand AI lists acute sinusitis, acute skin infection, alzheimer's disease, anxiety, arthritis, asthma, bladder disease and chronic diabetes among the conditions Danielle Stephens treats.

CMS data shows 2,177 Medicare services from Danielle Stephens across 13 procedure codes in 2024, for 505 Medicare patients. Medicare paid $108,073 for them. Every service was in an office.

CMS counts 505 Medicare patients who saw Danielle Stephens in 2024. The largest group is 75 to 84, with 191 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.88, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Danielle Stephens' median patient age at 60, with 53% women.

In 2024, Danielle Stephens wrote 1,948 Medicare Part D claims for 377 patients. 84% of them were for generic drugs. CMS names the drug for 1,397 of them, across 51 drugs with 11 or more claims each, at $106,448 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Danielle Stephens for performance year 2024, reported individually. Danielle Stephens accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 34 general payments to Danielle Stephens from 13 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $285.